Literature DB >> 3281933

Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma.

C B Hesler1, A R Tall, T L Swenson, P K Weech, Y L Marcel, R W Milne.   

Abstract

A cholesteryl ester transfer protein (CETP) of apparent Mr 74,000 has recently been purified from human plasma. Three monoclonal neutralizing antibodies to the CETP were obtained by immunizing mice with purified CETP. The antibodies, each recognizing a similar epitope on CETP, caused parallel and complete immunotitration of plasma cholesteryl ester and triglyceride transfer activities but only partial inhibition of phospholipid transfer activity. Monoclonal immunoaffinity chromatography of plasma or its fractions showed complete removal of cholesteryl ester and triglyceride transfer activities but incomplete removal of phospholipid transfer activity. Sodium dodecyl sulfate gel electrophoresis and immunoblotting of the immunoaffinity-retained fractions showed that only the Mr 74,000 protein was immunoreactive. The results suggest that the previously characterized CETP accounts for all of the cholesteryl ester and triglyceride transfer activity in human plasma but only part of the phospholipid transfer activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure.

Authors:  V Guyard-Dangremont; V Tenekjian; V Chauhan; S Walter; P Roy; E Rassart; A R Milne
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activity.

Authors:  K M Wasan; R Subramanian; J W Chou; M Ramaswamy; P H Pritchard
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.

Authors:  M M Wurfel; E Hailman; S D Wright
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

Review 4.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

5.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

6.  Cholesteryl ester analogs inhibit cholesteryl ester but not triglyceride transfer catalyzed by the plasma cholesteryl ester-triglyceride transfer protein.

Authors:  S J Busch; J A Harmony
Journal:  Lipids       Date:  1990-04       Impact factor: 1.880

7.  Cholesteryl ester transfer proteins from different species do not have equivalent activities.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2013-12-01       Impact factor: 5.922

8.  Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.

Authors:  E M Quinet; L B Agellon; P A Kroon; Y L Marcel; Y C Lee; M E Whitlock; A R Tall
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  Cyclosporine binds to the neutral lipid and potentially other binding sites of lipid transfer protein I.

Authors:  Mona Kwong; Kishor M Wasan
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

10.  Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

Authors:  Y L Marcel; R McPherson; M Hogue; H Czarnecka; Z Zawadzki; P K Weech; M E Whitlock; A R Tall; R W Milne
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.